Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
SQ
|
Roelof Botha
Director |
SELL
Other acquisition or disposition
|
Indirect | 4,988,486 Reduced 84.38% |
-
|
Feb 28
2019 |
SQ
|
Roelof Botha
Director |
BUY
Conversion of derivative security
|
Indirect | 4,718,493 Added 50.0% |
-
|
Feb 28
2019 |
SQ
|
Roelof Botha
Director |
BUY
Other acquisition or disposition
|
Indirect | 187,882 Added 37.35% |
-
|
Feb 28
2019 |
SQ
|
Ajmere Dale
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 2,048 Reduced 2.5% |
$163,840
$80.0 p/Share
|
Feb 28
2019 |
ARE
|
Stephen Richardson
Co-Chief Executive Officer |
SELL
Bona fide gift
|
Direct | 1,600 Reduced 0.88% |
-
|
Feb 28
2019 |
TRU
|
David M Neenan
President, International |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 10.59% |
$975,000
$65.0 p/Share
|
Feb 28
2019 |
TRU
|
Timothy Elberfeld
SVP and CAO |
SELL
Open market or private sale
|
Direct | 1,789 Reduced 11.29% |
$116,285
$65.0 p/Share
|
Feb 28
2019 |
CCK
|
Robert H Bourque Jr
President - Transit Packaging |
SELL
Payment of exercise price or tax liability
|
Direct | 336 Reduced 0.71% |
$18,241
$54.29 p/Share
|
Feb 28
2019 |
CCK
|
Timothy J Donahue
President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,709 Reduced 0.85% |
$255,652
$54.29 p/Share
|
Feb 28
2019 |
CCK
|
Thomas A Kelly
Senior Vice President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 624 Reduced 0.54% |
$33,877
$54.29 p/Share
|
Feb 28
2019 |
CCK
|
Gerard H Gifford
EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 789 Reduced 0.55% |
$42,835
$54.29 p/Share
|
Feb 28
2019 |
CCK
|
Djalma Novaes Jr
EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 561 Reduced 0.88% |
$30,457
$54.29 p/Share
|
Feb 28
2019 |
SNX
|
Kevin M Murai
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 112 Reduced 0.86% |
$10,989
$98.12 p/Share
|
Feb 28
2019 |
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect | 60,890 Added 0.48% |
$2,484,312
$40.8 p/Share
|
Feb 28
2019 |
GROW
|
Jerold H Rubinstein
Director |
BUY
Other acquisition or disposition
|
Direct | 100 Added 1.56% |
$131
$1.31 p/Share
|
Feb 28
2019 |
GROW
|
Thomas F Lydon Jr
Director |
BUY
Other acquisition or disposition
|
Direct | 100 Added 0.67% |
$131
$1.31 p/Share
|
Feb 28
2019 |
GROW
|
Roy D Terracina
Director |
BUY
Other acquisition or disposition
|
Direct | 100 Added 0.16% |
$131
$1.31 p/Share
|
Feb 28
2019 |
GROW
|
Lisa Callicotte
CFO |
BUY
Other acquisition or disposition
|
Direct | 90 Added 0.51% |
$118
$1.31 p/Share
|
Feb 28
2019 |
HAIN
|
Welling Glenn W.
Director |
BUY
Open market or private purchase
|
Indirect | 614,628 Added 9.08% |
$11,850,028
$19.28 p/Share
|
Feb 28
2019 |
GASS
|
Glendon Capital Management LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 50,000 Added 0.91% |
$164,500
$3.29 p/Share
|
Feb 28
2019 |
TCBI
|
Ian J Turpin
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 506 Reduced 5.44% |
$30,790
$60.85 p/Share
|
Feb 28
2019 |
TCBI
|
Ian J Turpin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 1,800 Added 16.21% |
$29,430
$16.35 p/Share
|
Feb 28
2019 |
TCBI
|
Ian J Turpin
Director |
SELL
Open market or private sale
|
Direct | 1,294 Reduced 14.71% |
$78,572
$60.72 p/Share
|
Feb 28
2019 |
SSB
|
Keith S Rainwater
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 500 Reduced 7.52% |
$35,500
$71.0 p/Share
|
Feb 28
2019 |
PNFP
|
M Terry Turner
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 11,355 Reduced 2.78% |
$669,150
$58.93 p/Share
|
Feb 28
2019 |
PNFP
|
Robert A Mccabe Jr
CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Direct | 10,760 Reduced 2.8% |
$634,087
$58.93 p/Share
|
Feb 28
2019 |
PNFP
|
Hugh M Queener |
SELL
Payment of exercise price or tax liability
|
Direct | 1,795 Reduced 0.77% |
$105,779
$58.93 p/Share
|
Feb 28
2019 |
PNFP
|
Harold R Carpenter
EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,795 Reduced 1.83% |
$105,779
$58.93 p/Share
|
Feb 28
2019 |
PNFP
|
J. Harvey White
Chief Credit Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,795 Reduced 3.69% |
$105,779
$58.93 p/Share
|
Feb 28
2019 |
CHCO
|
Charles R Hageboeck
President & CEO |
SELL
Open market or private sale
|
Direct | 1,593 Reduced 2.71% |
$126,644
$79.5 p/Share
|
Feb 28
2019 |
CHCO
|
Craig G Stilwell
EVP Retail Banking |
SELL
Open market or private sale
|
Direct | 2,431 Reduced 10.51% |
$193,532
$79.61 p/Share
|
Feb 28
2019 |
CVS
|
Thomas M Moriarty
EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 6,120 Reduced 15.98% |
$353,920
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Thomas M Moriarty
EVP & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 10,869 Added 22.1% |
$628,554
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Eva C Boratto
EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 1,893 Added 4.13% |
$109,472
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Eva C Boratto
EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,101 Reduced 2.55% |
$63,671
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Larry J Merlo
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 27,731 Reduced 7.63% |
$1,603,684
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Larry J Merlo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 33,431 Added 8.42% |
$1,933,315
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
James David Clark
SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,323 Added 12.71% |
$76,509
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
James David Clark
SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 288 Reduced 3.26% |
$16,655
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Jonathan C Roberts
EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 27,183 Added 11.55% |
$1,571,993
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Alan Lotvin
EVP&President-PharmacyServices |
BUY
Grant, award, or other acquisition
|
Direct | 6,342 Added 29.52% |
$366,758
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Alan Lotvin
EVP&President-PharmacyServices |
SELL
Payment of exercise price or tax liability
|
Direct | 292 Reduced 5.03% |
$16,886
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,114 Reduced 5.14% |
$237,913
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,477 Added 10.59% |
$548,055
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Joshua Matthew Flum
EVP, ENT STRATEGY & DIGITAL |
BUY
Grant, award, or other acquisition
|
Direct | 1,268 Added 7.25% |
$73,328
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Joshua Matthew Flum
EVP, ENT STRATEGY & DIGITAL |
SELL
Payment of exercise price or tax liability
|
Direct | 990 Reduced 6.21% |
$57,252
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Joshua Matthew Flum
EVP, ENT STRATEGY & DIGITAL |
BUY
Grant, award, or other acquisition
|
Direct | 2,297 Added 11.45% |
$132,836
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Kevin Hourican
EVP & President, CVS Pharmacy |
BUY
Grant, award, or other acquisition
|
Direct | 9,467 Added 49.19% |
$547,477
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Kevin Hourican
EVP & President, CVS Pharmacy |
SELL
Payment of exercise price or tax liability
|
Direct | 4,489 Reduced 93.52% |
$259,599
$57.83 p/Share
|
Feb 28
2019 |
CVS
|
Lisa Bisaccia
Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,015 Reduced 10.75% |
$174,357
$57.83 p/Share
|
Feb 28
2019 |